ABSTRACT AIM: To study the cholestatic forms of viral hepatitis A that are described as unusual and very rare, but that are of great signifi cance because of their severe course and high morbidity rate. MATERIAL AND METHODS: We describe herein 17 cases of hepatitis A virus (HAV) infection with pronounced cholestasis treated in the Clinic of Infectious Diseases at St. George University Hospital between 2002 and 2006. They are taken from a contingent of 820 patients we studied in the course of the research: of these 400 were cases of sporadic disease and 420 patients were involved in an epidemic outbreak of the disease. All got this diagnosis based on an anti-HAV/IgM test. Eight parameters were analyzed: age, max TBil, max ALT, ALP, GGT, no urobilinogen in urine, ultrasound monitoring of hepatomegaly, and hospital stay. RESULTS: The 17 patients we discuss here are 2.07% of the total 820 patients with viral hepatitis A (VHA). In 14 the disease had a cholestatic component; 3 cases were a cholestatic form of the disease. The mean hospital stay was 49.1 ± 11.5 days, the longest -75 days. The hyperbilirubinemia had high levels at the disease climax -the mean concentration was 356.6 μkmol/l, and remained greater than 150 μkmol/l for more than a month. In 10 patients (58.2%) transaminase activity was over 1400 U/l, (mean 2011 U/l). CONCLUSION: Viral hepatitis A ran with cholestatic syndrome in 2.07%; 23.5% of these cases were classifi ed as severe forms of the disease and 76.5% -as moderate. This is evinced by the enhanced transaminase activity, the elevated TBil, pronounced intoxication, the adynamia, vomiting, headache, the vertigo, all of these items in the objective severity score system we used.
INTRODUCTION
After a certain period of stagnancy in the research of hepatitis A virus, probably because hepatitis B and C viruses and the chronic disease they cause had attracted the researchers' interest more compellingly, there is a certain revival of the interest toward hepatitis A virus, its prevention and confi nement and eventual eradication in the future. 1, 2 Viral hepatitis A keeps being a problem for Plovdiv region and Bulgaria: there is the high incidence it has reaching 426º/оооо during the 2006 outbreak of the disease, the distinctive clinical diversity in the disease progression not only impairing the health, the psycho-social balance and working ability of the individual, but also infl icting great economic losses by the loss of working hours, working ability and creativity of large groups of people. 3, 4 Cholestasis is defined as disturbance in the production and excretion of bile that leads to biochemical, physiological, morphological and clinical alterations. 5 Cholestatic forms of VHA are rare and the correct defi nition is presence of cholestatic component in icteric cyclic form of the disease. 6, 7 Despite the pronounced pathomorphologic alterations, reliably showing intrahepatic cholestasis with limited necroses in the acinal region and periportal hepatitis with muff-like confl uating necroses surrounding the infl amed portal ducts 8 , clinically manifested cholestasis in HVA is rare and present primarily in elderly patients.
The AIM of the study was to analyze the frequency and clinical course of these forms in modern viral hepatitis A.
MATERIAL AND METHODS
We present here seventeen patients with viral hepatitis A (VHA) with pronounced cholestasis treated in the Clinic of Infectious diseases at St. George 
STATISTICS
Data were analysed using modern statistical software. The level of signifi cance was accepted to be at p < 0.05. We used in the study ANOVA for quantitative parameters -Student-Newman-Keuls criterion and graphical analysis of statistical data and their relation have been used.
RESULTS
During the period of observation the disease was accompanied by signifi cant cholestasis in 17 (2.07%) of 820 patients with VHA. Analysis shows that in 14 of them it is more correct to assume presence of cholestatic component -acute, cyclic icteric form, with markedly high aminotranspherases and overlapping cholestatic signs. Cholestatic form of VHA was found in 3 patients -moderate cytolysis with prevailing cholestatic parameters. In the studied sample, one patient was 17 years old, eight were females and eight were males between 27 and 62, with mean hospital stay of 49.1 ± 11.5 days and longest hospital stay of 75 days for a 27-year-old man. No statistically signifi cant difference between cholestatic sporadic cases -9 (52.9%) and epidemiologic ones -8 (47.1%) was found.
The basic hepatic functional parameters, including cholestatic enzymes are shown in Table 1 .
Pronounced manifestations of cholestasis are present in all patients: itching with skin scratches -in 13 patients; hypocholic and acholic faeces for 7 to 21 days (13.3 ± 4.3) -in 17 patients; no urine urobilinogen for a long period -in 14 patients; mild verdin hue of jaundice was present in patients with hyperbilirubinemia for more than In 10 patients transaminase activity is more than 1400 U/l at the peak of the disease -mean 2011 U/l, with highest value in a single patient -4923 U/l. ALT decrease during the fi rst decade compared to the levels at the time of hospital admission is statistically signifi cant (р < 0.001). They approximate the reference values at hospital release after hospital stay of 51 days (Fig. 1) .
According to our data, in 14 patients the acute jaundice form of VHA presented with pronounced cytolytic syndrome -e.g. hepatocellular type of injury (ALT/ALP ratio >5) overlapped with cholestatic symptoms -itching with scratching, acholic faeces, lack of urine urobilinogen, increase in serum alkaline phosphatase -ALP and γ-GT, especially prominent during the disease climax.
Hyperbilirubinemia over 200 μmol/l was present in almost all patients with cholestatic component (Fig. 2) .
Bilirubin levels are high during the disease climax -mean value 356.6 μkmol/l, and remain over 150 μkmol/l for more than a month. Bilirubin levels at hospital release are 2.5 times above the upper limit of the normal.
In three cases we were able to assume the cholestatic form of VHA (№№ 1, 7 ,14 in Table  1 ). They are presented separately in terms of ALT and membrane-bound enzymes (ALP and γ-GT) dynamics (Table 2) .
Transaminase activity is moderately increased -between 373 and 1071 U/l, ALP is signifi cantly increased, reaching 1533 IU/l in one patient, and γ-GT is 5-8 times more elevated in 2 and almost normal in 1 of the patients. The hospital stay is over 2 months with more than 20 days of lack of urobilinogen in urine in those 3 patients. An interesting fact is that two of the patients are 27 and 35 years old, and the third is 62 years old.
DISCUSSION
Our observations are consistent with the opinion of majority of authors that despite the pathomorphologic alterations, showing intrahepatic cholestasis in VHA, clinically manifested cases are rare and are found primarily in the elderly. [9] [10] [11] [12] A similar point of view is shared by WHO experts, who consider that cholestatic VHA with high bilirubin levels for months, is very rarely seen (WHO/CDS/CSR/EDC/2000). A plausible explanation of that fact is the suggestion of Eisenburg J that the lack of a chronic process and the temporary increase of bile capillaries permeability infl uence reversibly the osmotic gradient and the activity of Na+, К+, АТP-transport, and the disturbed production, secretion and drainage bile is partial. 13, 14 Our data support A. Bluger that cholestatic form of VHA is rare and presence of cholestatic component in cyclic form of VHA is a more correct defi nition. 9, 15, 16 We do not share his opinion that these forms are moderate or mild. In the 17 patients we followed (2.07% of 820 patients between 27 and 62 years old) we have not found mild hepatitis A. In 4 (23.5%) patients VHA was severe, and in 13 (76.5%) -moderate. A proof for that is high transaminase activity -mean ALT 2011.4 U/l, very high bilirubin at the peak of the diseaseTBil 356.6 μmol/l, as well as pronounced adynamia, intoxication, vomiting, headache and vertigo, etc., objectively assessed by a point-system, created by us. 17 The most signifi cant increase is in ALP and GGT: 403.3 U/l and 215.5 U/l, respectively. The fi ndings of other clinicians are similar. [18] [19] [20] Corpechot C, Cadranel JF report 9 cases of pronounced cholestasis in VHA between 1988 and 1992. Eight of them are in patients over 45 years old with an accompanying disease in 3 cases -chronic colitis, epilepsy and bronchial asthma, probably reinforcing the cholestasis. 21 The cases with pronounced cholestatic form of viral hepatitis A are defi ned as protracted, but with good prognosis (no chronifi cation) by Ferreira and Koff RS. 19, 22 Turkish authors describe a case of cholestatic hepatitis A in 14 year-old boy. Recovery is favourable 4 months after symptoms onset. 23 
CONCLUSIONS
Viral hepatitis A may present with cholestatic syndrome in 2.07% of the cases, 23.5% of them classifi ed as severe forms of disease, and 76.5% -as moderate. Hospital stay is long, but with no evidence for chronifi cation. 
